SEARCH

UPCOMING LIVE SEMINARS
 
CRA & CRC: Beginner Program
December 2-4, 2014
Philadelphia, PA
Clinical Project Management: Intermediate
December 2-3, 2014
San Diego, CA
Comprehensive Monitoring for Medical Devices
December 9-11, 2014
San Diego, CA






Final FDA Guidance: How to Complete the FDA Form 1572, Adequately and Accurately November 2011

Course Description

Proper completion of the Statement of Investigator has been greatly debated. Many stakeholders differ in opinions on what is accurate and adequate in completing this form. For example, who should be listed as subinvestigators, do we need to complete a 1572 for certain projects, and so forth. This web seminar will review the 2010 FDA information sheet and answer many of the questions about how to properly complete the form. The course will also discuss what is still not clear even after the guidance and how to get the answers.

VideoPreview

 

Learning Objectives

  • Review significant final guidance content
  • Detail form completion clarifications for key debated sections
  • Assess impact on current practices
  • Review case studies of documented deficiencies of the form in warning letters and map the guidance to other FDA initiatives

Who Should Attend

  • Site Research Managers and Coordinators
  • Investigators
  • Clinical Research Monitors
  • Project and CRA Managers
  • Clinical Research Directors
  • Regulatory Affairs Professionals
  • Sponsor/CROs
  • CRAs
  • CRCs

Instructor

Karen L. Gilbert, B.S., C.C.R.A.

Click here for complete trainer biographies 

Course Length Time

2 hours; 12:00 - 2:00 p.m. Eastern

Course Dates

November 16, 2011

Hold this course at your company!
For more information, contact Naila Ganatra at (215) 413-2471.